Double-blind, placebo-controlled, 1:1 randomized Phase III clinical trial of Immunoxel honey lozenges as an adjunct immunotherapy in 269 patients with pulmonary tuberculosis von Batbold, Uyanga, Butov, Dmytro O, Kutsyna, Galyna A, Damdinpurev, Narantsetseg, Grinishina, Elena A, Mijiddorj, Otgonbayar, Kovolev, Mikola E, Baasanjav, Khaliunaa, Butova, Tatyana S, Sandagdorj, Munkhburam, Batbold, Ochirbat, Tseveendorj, Ariungerel, Chunt, Erkhemtsetseg, Zaitzeva, Svetlana I, Stepanenko, Hanna L, Makeeva, Natalia I, Mospan, Igor V, Pylypchuk, Volodymyr S, Rowe, John L, Nyasulu, Peter, Jirathitikal, Vichai, Bain, Allen I, Tarakanovskaya, Marina G, Bourinbaiar, Aldar S

Volltext